In the past decade, there have been significant advancements in targeted antibody-based immunotherapies for managing r/r ...

A liver-first treatment approach in primary and colorectal liver metastases (CRLM) is associated with worse recurrence-free survival (RFS) than primary-first or simultaneous treatment approaches, ...

Patients who achieved a pathologic complete response after neoadjuvant therapy had better survival outcomes than patients who received adjuvant therapy.

Ovarian cancer detected with specificity >99 percent and sensitivity ranging from 69 to 100 percent depending on stage.

Intensive chemotherapy combined with second- or third-generation tyrosine kinase inhibitors improves survival in patients ...

Researchers sought to elucidate different patterns of disease response in pediatric patients with B-ALL vs T-ALL.

Treatment with cediranib or cediranib plus olaparib is not superior to standard of care (SOC) in patients with platinum-resistant or -refractory epithelial ovarian cancer, according to results from a ...

Despite the ongoing debate, study finding support retaining the “cancer” designation for patients with Gleason grade group 1 ...

In the years since targeted treatments for CLL were introduced, their use in the second line has increased, but chemotherapy ...

The overall incidence rates for all cancer sites and specific cancer sites returned to prepandemic levels in 2021, according ...

Survey results suggest that cancer patients want financial toxicity screening to occur early, but screening preferences and practices vary.

Researchers sought to determine factors associated with mortality for patients with AML and hyperleukocytosis.